Results 141 to 150 of about 103,351 (342)
Botulinum toxin in management of back pain
Introduction The botulinum toxin is a widely used therapeutic agent. It is used for aesthetic reasons in treatment of glabellar wrinkles. Therapeutic indications include cervical dystonia, hyperhidrosis or migrenes.
Blanka Łuczak +9 more
doaj +1 more source
ABSTRACT Aim Treating multiple sclerosis (MS)‐related adult neurogenic lower urinary tract dysfunction (ANLUTD) is challenging because conservative treatments are often ineffective. Sacral neuromodulation (SNM) is a promising minimally invasive treatment of ANLUTD. This review assesses the efficacy and safety of SNM for MS‐related ANLUTD.
Carlos Ferreira +8 more
wiley +1 more source
POSTGANGLIONIC PARALYSIS OF THE GUINEA‐PIG HYPOGASTRIC NERVE‐VAS DEFERENS PREPARATION BY CLOSTRIDIUM BOTULINUM TYPE D TOXIN [PDF]
D. A. WESTWOOD, B.C. Whaler
openalex +1 more source
ABSTRACT Introduction Management of overactive bladder (OAB) has a stepwise approach in adults and children. This does not account for individual patient variations, which may explain suboptimal outcomes in many patients. Distinct OAB profiles, based on patient characteristics, symptoms, urodynamic findings and imaging have been discussed in Part 1 ...
Michel Wyndaele +9 more
wiley +1 more source
Use of Immunofluorescence and Animal Tests to Detect Growth and Toxin Production by Clostridium botulinum Type E in Food [PDF]
T. F. Midura +4 more
openalex +1 more source
Abstract Objective To perform a secondary review of low back pain (LBP) clinical practice guidelines (CPG) identified in a recently conducted systematic review and to synthesize and summarize low‐value recommendations as practices that may be candidates for deimplementation.
Daniel Tai +5 more
wiley +1 more source
Classification of intestinomotor drugs by means of type D botulinum toxin
N Ambache, A. W. Lessin
openalex +2 more sources
Abstract Background Pain is often observed in patients with spasticity, but little is known about the relationship between pain and spasticity and the effectiveness of treating pain with botulinum toxins in these patients. Objective To explore onabotulinumtoxinA (onabotA) use and pain relief in patients with spasticity with pain at baseline.
Jörg Wissel +5 more
wiley +1 more source

